Arjun Ranjan Sarker - 06 Mar 2023 Form 4/A - Amendment Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role: Senior VP, International
Signature: /s/ Mojirade James, as attorney-in-fact for Arjun Sarker
Issuer symbol: AVNS
Transactions as of: 06 Mar 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 23 Mar 2023, 11:32:53 UTC
Date Of Original Report: 07 Mar 2023
Previous filing: 08 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVNS	Common Stock	Award	$0	+4,562	+21%	$0.000000	26,761	06 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026.

Remarks:

This Form 4/A is being filed to correct an error in the calculation of the number of time-based restricted share units issued to the Reporting Person on March 6, 2023 pursuant to the Issuer's 2021 Long-Term Incentive Plan.